Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Okamura

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Vaccine|August 24, 2021
Could live attenuated vaccines better control COVID-19?Shinya Okamura, Hirotaka Ebina
Scientific Reports|January 31, 2023
A highly sensitive NanoLuc-based protease biosensor for detecting apoptosis and SARS-CoV-2 infectionMasashi Arakawa, Akiho Yoshida, Shinya Okamura, et al.
STAR Protocols|June 10, 2023
Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutationsShinya Okamura, Akiho Yoshida, Paola Miyazato, et al.
Journal of Prosthodontic Research|November 9, 2019
In vitro investigation of fracture load and aging resistance of high-speed sintered monolithic tooth-borne zirconia crownsTakashi Nakamura, Yoshiro Nakano, Hirofumi Usami, et al.
Dental Materials Journal|March 29, 2021
Fluorescence and physical properties of thulium and erbium co-doped dental zirconiaTakashi Nakamura, Shinya Okamura, Hisataka Nishida, et al.
Dental Materials Journal|August 31, 2018
Fluorescence of thulium-doped translucent zirconiaTakashi Nakamura, Shinya Okamura, Hisataka Nishida, et al.
Biochimica Et Biophysica Acta|March 4, 2015
Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activitiesShinya Okamura, Eri Nishiyama, Tomohiro Yamazaki, et al.
Iscience|November 2, 2022
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunityAkiho Yoshida, Shinya Okamura, Shiho Torii, et al.
The Journal of Clinical Investigation|December 1, 2023
Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responsesAtsushi Kawai, Nagisa Tokunoh, Eigo Kawahara, et al.
Elife|February 11, 2025
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanismsMie Suzuki Okutani, Shinya Okamura, Tang Gis, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Vaccine|August 24, 2021
Could live attenuated vaccines better control COVID-19?Shinya Okamura, Hirotaka Ebina
Scientific Reports|January 31, 2023
A highly sensitive NanoLuc-based protease biosensor for detecting apoptosis and SARS-CoV-2 infectionMasashi Arakawa, Akiho Yoshida, Shinya Okamura, et al.
STAR Protocols|June 10, 2023
Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutationsShinya Okamura, Akiho Yoshida, Paola Miyazato, et al.
Journal of Prosthodontic Research|November 9, 2019
In vitro investigation of fracture load and aging resistance of high-speed sintered monolithic tooth-borne zirconia crownsTakashi Nakamura, Yoshiro Nakano, Hirofumi Usami, et al.
Dental Materials Journal|March 29, 2021
Fluorescence and physical properties of thulium and erbium co-doped dental zirconiaTakashi Nakamura, Shinya Okamura, Hisataka Nishida, et al.
Dental Materials Journal|August 31, 2018
Fluorescence of thulium-doped translucent zirconiaTakashi Nakamura, Shinya Okamura, Hisataka Nishida, et al.
Biochimica Et Biophysica Acta|March 4, 2015
Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activitiesShinya Okamura, Eri Nishiyama, Tomohiro Yamazaki, et al.
Iscience|November 2, 2022
Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunityAkiho Yoshida, Shinya Okamura, Shiho Torii, et al.
The Journal of Clinical Investigation|December 1, 2023
Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responsesAtsushi Kawai, Nagisa Tokunoh, Eigo Kawahara, et al.
Elife|February 11, 2025
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanismsMie Suzuki Okutani, Shinya Okamura, Tang Gis, et al.
Pageof 2